Indication
Eosinophilic Gastrointestinal Disease
1 clinical trial
2 products
Clinical trial
A Phase 2/3, Randomized, 3-Part Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Gastritis With or Without Eosinophilic DuodenitisStatus: Recruiting, Estimated PCD: 2027-08-19
Product
Matching PlaceboProduct
Dupilumab